pentoxifylline has been researched along with Bone Cancer in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we discussed the combined effects of CDDP and caffeine or pentoxifylline using human osteosarcoma cells (OST strain)." | 3.67 | [DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors]. ( Sasaki, T; Tomita, K; Tsuchiya, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janovszky, Á | 1 |
| Vereb, T | 1 |
| Szabó, A | 1 |
| Piffkó, J | 1 |
| Owosho, AA | 1 |
| Estilo, CL | 1 |
| Huryn, JM | 1 |
| Yom, SK | 1 |
| Tomita, K | 1 |
| Tsuchiya, H | 1 |
| Sasaki, T | 1 |
1 review available for pentoxifylline and Bone Cancer
| Article | Year |
|---|---|
[Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
Topics: alpha-Tocopherol; Analgesics; Anti-Bacterial Agents; Biomarkers; Bisphosphonate-Associated Osteonecr | 2014 |
2 other studies available for pentoxifylline and Bone Cancer
| Article | Year |
|---|---|
Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series.
Topics: Aged; Antioxidants; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Ag | 2016 |
[DNA repair and drug resistance: enhancement of the effects of anticancer agents by DNA repair inhibitors].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Cell Division; | 1989 |